US Patent 7351567 Enzymatic resolution of selective estrogen receptor modulators

Patent 7351567 was granted and assigned to Pfizer on April, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Pfizer

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7351567

Date of Patent

April 1, 2008

Patent Application Number

10791462

Date Filed

March 2, 2004

Patent Primary Examiner

‌

Christopher R. Tate

Patent abstract

The present invention relates to a process for preparing 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen-2-ol compounds useful as an estrogen agonist.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7351567 Enzymatic resolution of selective estrogen receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API